Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← All stories
IndustryJune 8, 2026

ADA Conference Highlights Obesity Drug Competition and Clinical Practice Gaps

The American Diabetes Association's annual conference featured industry discussions on the competitive landscape for GLP-1 obesity medications and identified clinical blind spots in diabetes care delivery. The conference addressed how pharmaceutical competition is shaping market access and pricing dynamics for widely-used medications including semaglutide and tirzepatide. For Medicaid managed care organizations, these developments directly affect formulary strategy, prior authorization protocols, and budget forecasting for one of the fastest-growing drug spending categories.

Why it mattersMedicaid MCOs face escalating costs and utilization management challenges for GLP-1 medications, which represent significant budget pressure while state coverage policies and clinical criteria continue to evolve rapidly.

Managed Care · Pharmacy

Read the full article at statnews.com →
Share this briefing

You might also like

← All stories

Get the daily briefing.